How Healthcare M&A Firms Package Add-Backs Without Damaging Credibility
How Healthcare M&A Firms Package Add-Backs Without Damaging Credibility Key Takeaways Why Add-Back Packaging Can Make or Break Deal Credibility In healthcare deals, buyers don’t hate add-backs—they hate unverified add-backs. The goal is a clean bridge from “books EBITDA” to “buyer-ready EBITDA” that can survive Quality of Earnings. Use an evidence-first mindset like QoE readiness […]
Read More
How Healthcare Agencies Use Marketing + Banking Data to Strengthen Buyer Confidence
How Healthcare Agencies Use Marketing + Banking Data to Strengthen Buyer Confidence Key Takeaways Why do buyers hesitate when the numbers feel “soft.” In healthcare transactions, buyer confidence drops when growth is presented as a narrative instead of a verifiable system. Agencies that package clean KPIs, consistent definitions, and reconciled reporting reduce uncertainty early. […]
Read More
How CEOs Are Using AI-Driven Due Diligence to Avoid Value Erosion in 2026 Deals
How CEOs Are Using AI-Driven Due Diligence to Avoid Value Erosion in 2026 Deals Key Takeaways Why Value Erosion Has Become a Critical Threat in 2026 M&A Deals In 2026, mergers and acquisitions are moving faster—but they are also breaking down more expensively. CEOs across healthcare, MedSpa, and provider-based businesses are discovering that value erosion […]
Read More